INTRODUCTION AND OBJECTIVES: During radical prostatectomy cancer abutting or focally extending beyond the prostate capsule increases the risk of a positive surgical margin. Thus, intraoperative knowledge of the three-dimensional (3D) location of cancer can help the surgeon reducing this risk. We specifically developed an Elastic Augmented-Reality (AR) system based on elastic HyperAccuracy 3D reconstruction (HA3DTM), that simulates prostate deformation during the procedure. The aim of this study is to evaluate the accuracy of this 3D Elastic AR system in identifying capsular involvement (CI) of PCa during the NS phase of robot-assisted radical prostatectomy (RARP).
INTRODUCTION AND OBJECTIVES:
To introduce the technique and report our initial experience of transvesical robot assisted radical prostatectomy (TvRARP).
METHODS: 10 TvRARP for prostate cancer performed by a single surgical team between 2018 April and 2018 October were retrospectively reviewed. Preoperative data of patients [patient age (58.6AE9.4) years, BMI (26.5AE3.1) kg/m2, tPSA (19.5AE4.1) ng/ml, biopsy Gleason score 6(6w7), prostate volume (33.4AE15.8)ml and IIEF-5 score 12(10w16)] were collected. Preoperative study revealed 8 cases of cT1c, 1 case of cT2a and 1 case of cT2b. All patients were continent preoperatively. The surgery was performed with da Vinci Si system via 4 robotic ports and 2 assistant ports as the following: 1) cystotomy, further expended by bilateral suspension stitches. 2) A circumferential incision is made around the internal urethral orifice through the mucosa and muscular layer. 3) Initial dissection of the vas deferens and semi vesicles is carried out through the lower half of the circumferential incision around the internal urethral orifice. 4) Posterior dissection towards the apex of the prostate. 5) Dissection of bilateral NVB. 6) Anterior dissection towards the apex of the prostate. 7) Dissection and transection of the urethra. 8) Urethrovesical anastomosis. 9) 2-layer closure of bladder.
RESULTS: All 10 cases were successfully performed robotically without conversion, transfusion or other major intraoperative and postoperative complications. Postoperative pathology confirmed 6 pT2a cases, 3 pT2b cases and 1 pT2c case [Gleason score 6(6w7)]. 1 case reported positive surgical margin (10%). Operative time was (140.5AE35.5) min. Estimated blood loss was (65.5AE35.5) ml. Urethral catheter was removed at postoperative 7-day. 9 patients achieved urinary continence (0 pads) immediately after the removal of urinary catheter, while 1 patient returned to full continence in 2 weeks postoperatively. During a mean follow up of 3 months (2w4 months), no biochemical recurrence was noted (tPSA<0.2ng/ml). At 2-month postoperatively, IIEF-5 score was 11(8w13) and not statistically different from preoperative status (p > 0.05).
CONCLUSIONS: Transvesical approach is a valid alternative of performing RARP in patients bearing localized low-risk prostate cancer. Tumor control and preservation of erectile function remains to be determined in long term follow up.
